What's new

Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised

May 26, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, ...

Next Article

Floseal haemostatic matrix (Floseal VH S/D) - Procedural steps and scientific in...

Related Posts

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

ICH M12 on drug interaction studies - Scientific guideline

ICH M12 on drug interaction studies - Scientific guideline

May 23, 2025  0

EMEA-000639-PIP03-16-M03

EMEA-000639-PIP03-16-M03

May 15, 2025  0